EFFECT OF DIHYDROQUERCETIN ON THE WEIGHT OF EXPERIMENTAL ANIMALS: REVIEW
- 20 April 2026
- journal article
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 129
Abstract
Obesity is a distinct disease that leads to severe health issues like diabetes, heart disease, and cancer. The spread of this pathology can be compared to an epidemic. The search for medications for weight control remains an actual challenge for pharmaceutical and medical sciences. In particular, studying the anorexigenic effect of the flavanol dihydroquercetin (DHQ) is of special interest. Bibliographic databases contain a lot of studies reporting the dynamics of weight changes on the background of taking this flavonoid, and recent studies have shown that DHQ promotes weight loss. Therefore, the aim of this article is to assess the data of experimental studies on the effect of DHQ on the body weight of experimental animal model compared to control groups. The study results demonstrate statistically significant weight loss in mice and rats with various pathologies within the first month of DHQ administration. The biological effect of the flavonoid under the described conditions was comparable to the effect of GLP-1 receptor agonists. Thus, if the results of fundamental research are successfully translated into clinical practice, the use of this flavonoid will make it possible to reduce therapeutic doses of standard medications and will provide administration for patients requiring mild pharmacological intervention. This could improve the life quality of 483 million patients worldwide. Realization of this strategy would reduce the procurement and production of GLP-1 receptor agonists, which, given the high cost of treatment, would reduce the economic burden on the healthcare system. A systematic review identified a number of challenges for pharmaceutical science that require solutions for the successful development of a drug based on DHQ. In particular, future research should focus on studying the influence of flavanonol stereochemistry on its biological effect, as well as on identifying modifications with improved bio-availability and optimal dosage form.Keywords
This publication has 45 references indexed in Scilit:
- Medical and Pharmaceuticals from Biological Resources in the Global South2025
- Hepatoprotective potential of taxifolin in type 2 diabetic rats: modulation of oxidative stress and Bcl2/Bax/Caspase-3 signaling pathwayMolecular Biology Reports, 2024
- Mechanisms of weight regain.European Journal of Internal Medicine, 2021
- The anti‐obesity and gut microbiota modulating effects of taxifolin in C57BL/6J mice fed with a high‐fat dietJournal of the Science of Food and Agriculture, 2021
- Comparative Study of Wound-Healing Activity of Dihydroquercetin Pseudopolymorphic ModificationsBulletin of Experimental Biology and Medicine, 2021
- In vitro anti-inflammatory and anti-lipid accumulation properties of taxifolin-rich extract from the Japanese larch, Larix kaempferiHeliyon, 2020
- Dataset on body weight and length of rainbow trout, Oncorhynchus mykiss, fed with dihydroquercetin, arabinogalactan or a mixture of both in an aquaria experimentData in Brief, 2020
- Metformin: Mechanisms in Human Obesity and Weight LossCurrent Obesity Reports, 2019
- Use of a new antioxidant diquertin as an adjuvant in the therapy of patients with acute pneumoniaPhytotherapy Research, 1998
- Antioxidant Activity of a Dihydroquercetin Isolated from Larix gmelinii (Rupr.) Rupr. WoodPhytotherapy Research, 1996